Department of Pharmaceutical Technology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eur J Pharm Biopharm. 2011 Jan;77(1):122-31. doi: 10.1016/j.ejpb.2010.09.017. Epub 2010 Oct 8.
The present study investigates the use of nimodipine-polyethylene glycol solid dispersions for the development of effervescent controlled release floating tablet formulations. The physical state of the dispersed nimodipine in the polymer matrix was characterized by differential scanning calorimetry, powder X-ray diffraction, FT-IR spectroscopy and polarized light microscopy, and the mixture proportions of polyethylene glycol (PEG), polyvinyl-pyrrolidone (PVP), hydroxypropylmethylcellulose (HPMC), effervescent agents (EFF) and nimodipine were optimized in relation to drug release (% release at 60 min, and time at which the 90% of the drug was dissolved) and floating properties (tablet's floating strength and duration), employing a 25-run D-optimal mixture design combined with artificial neural networks (ANNs) and genetic programming (GP). It was found that nimodipine exists as mod I microcrystals in the solid dispersions and is stable for at least a three-month period. The tablets showed good floating properties and controlled release profiles, with drug release proceeding via the concomitant operation of swelling and erosion of the polymer matrix. ANNs and GP both proved to be efficient tools in the optimization of the tablet formulation, and the global optimum formulation suggested by the GP equations consisted of PEG=9%, PVP=30%, HPMC=36%, EFF=11%, nimodipine=14%.
本研究探讨了尼莫地平-聚乙二醇固体分散体在制备泡腾控释漂浮片制剂中的应用。采用差示扫描量热法、粉末 X 射线衍射、傅里叶变换红外光谱和偏光显微镜对分散在聚合物基质中的尼莫地平的物理状态进行了表征,并优化了聚乙二醇(PEG)、聚乙烯吡咯烷酮(PVP)、羟丙基甲基纤维素(HPMC)、泡腾剂(EFF)和尼莫地平的混合比例,以考察药物释放(60 分钟时的释放百分比和 90%药物溶解所需的时间)和漂浮性能(片剂的漂浮强度和持续时间),采用 25 次运行的 D-最优混合设计结合人工神经网络(ANNs)和遗传编程(GP)。结果发现,尼莫地平在固体分散体中以 I 型微晶形式存在,并且至少在三个月内是稳定的。这些片剂表现出良好的漂浮性能和控释特性,药物释放是通过聚合物基质的溶胀和侵蚀的共同作用进行的。ANNs 和 GP 都被证明是优化片剂配方的有效工具,而 GP 方程建议的全局最优配方由 PEG=9%、PVP=30%、HPMC=36%、EFF=11%、尼莫地平=14%组成。